Journal of the European Academy of Dermatology and Venereology · 2022 · 20 citations · 43 references
AgricultureNutritionNutritional SciencesClinical NutritionHuman NutritionInflammationAntiretroviral TherapyMedical Nutrition TherapyMetabolic InflammationDietary Fatty AcidsDietary Supplementation EffectsFatty AcidsGut Microbiota DysbiosisNutritional Modulation Of ImmunityOmega-6 Fatty AcidsShort-chain Fatty Acid TherapyT-cell Immune Responses
BACKGROUND: Non-AIDS-associated chronic diseases in HIV+ patients have been on the rise since the advent of antiretroviral therapy. Especially cardiovascular diseases and disruption in the gastrointestinal tract have limited health-related quality of life (QoL). Several of those complications have been associated with chronic systemic inflammation. Short-chain fatty acids (SCFA), with propionate as one of the major compounds, have been described as an important link between gut microbiota and the immune system, defining the pro- and the anti-inflammatory milieu through direct and indirect regulation of T-cell homeostasis. The effects of dietary supplementation of sodium propionate (SP) in people living with HIV (PLHIV) have not yet been investigated prior to this study. OBJECTIVES: To investigate the impact of SP uptake among PLHIV and its relevance to improve QoL, the study aimed to investigate metabolic, immunological, microbiome and patient-reported QoL-related changes post-SP supplementation with follow-up. METHODS: A prospective, non-randomized, controlled, monocentric interventional study was conducted in WIR, Center for Sexual Health and Medicine, in Bochum, Germany. 32 HIV+ patients with unaltered ART-regimen in the last three months were included. Participants were given SP for a duration of 12 weeks in the form of daily oral supplementation and were additionally followed-up for another 12 weeks. RESULTS: The supplementation of SP was well tolerated. We found an improvement in lipid profiles and long-term blood glucose levels. A decrease in pro-inflammatory cytokines and a depletion of effector T cells was observed. Regulatory T cells and IL-10 decreased. Furthermore, changes in taxonomic composition of the microbiome during follow-up were observed and improvement of items of self-reported life-quality assessment. CONCLUSION: Taken together, the beneficial impact of SP in PLHIV reflects its potential in improving metabolic parameters and modulating pro-inflammatory immune responses. Thus, possibly reducing the risk of cardiovascular disorders and facilitating long-term improvement of the gut flora.
43
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Nicholas Arpaia, Clarissa Campbell, Xiying Fan et al. · Nature · 2013 · 4.7K citations · Full text
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski, Angélica T. Vieira, Aylwin Ng et al. · Nature · 2009 · 3.2K citations
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
Filipe De Vadder, Petia Kovatcheva‐Datchary, Daisy Goncalves et al. · Cell · 2014 · 2.2K citations · Full text